Get the Stockscreener App
0.9811
6.25%
-0.059
Polyrizon Ltd stock is traded at $0.9811, with a volume of 3.27M.
It is down -6.25% in the last 24 hours and up +21.54% over the past month.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
See More
Previous Close:
$1.04
Open:
$0.92
24h Volume:
3.27M
Relative Volume:
0.74
Market Cap:
$5.22M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+36.69%
1M Performance:
+21.54%
6M Performance:
-99.73%
1Y Performance:
+0.00%
1-Day Range:
$0.8571
$1.03
1-Week Range:
$0.66
$1.33
52-Week Range:
$0.55
$1,200.00
Polyrizon Ltd Stock (PLRZ) Company Profile
Compare PLRZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
0.98 | 3.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.11 | 119.76B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.00 | 59.14B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
319.21 | 41.40B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
570.42 | 32.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
278.04 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Polyrizon Ltd Stock (PLRZ) Latest News
Polyrizon Plunges 11.06% Amid Market Challenges - AInvest
Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved - Benzinga
How Polyrizon Ltd. stock performs during market volatilitySmart Trading With Safety Margin - Newser
What makes Polyrizon Ltd. stock price move sharplyFree High-Accuracy Stock Picks - Newser
Polyrizon retains Nasdaq listing following hearings panel - MSN
Polyrizon secures continued Nasdaq listing after panel hearing By Investing.com - Investing.com Nigeria
Polyrizon secures continued Nasdaq listing after panel hearing - Investing.com
Polyrizon Ltd. Secures Continued Nasdaq Listing Following Compliance Plan Implementation - Quiver Quantitative
Polyrizon Retains Nasdaq Listing Following Hearings Panel - 富途牛牛
Why Polyrizon Ltd. stock attracts strong analyst attentionFast Moving Stock Alerts - Newser
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest - MSN
Polyrizon Ltd. Announces Board Changes and Confirms Independent Directors - The Globe and Mail
Polyrizon director Omer Srugo resigns; board affirms independent members - Investing.com
Polyrizon Ltd Inc. (PLRZ) Price Performance: How to Use Technical Analysis to Make Trading Decisions - investchronicle.com
Polyrizon’s nasal drug delivery system shows promising results By Investing.com - Investing.com South Africa
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics - MarketScreener
Polyrizon’s nasal drug delivery system shows promising results - Investing.com Australia
Polyrizon Announces Promising Preclinical Results for CNS Therapeutics - TipRanks
Revolutionary Nasal Drug Delivery System Could Transform Treatment of Opioid Overdose and Epilepsy - Stock Titan
Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq - GlobeNewswire
Smart Digital Group And Polyrizon See Unusual Market Moves - Finimize
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Polyrizon Soars 14.55% Post Reverse Stock Split - AInvest
Polyrizon Ltd. Announces Reverse Share Split Effective May 27, 2025 - TipRanks
Polyrizon recives Nasdaq delisting notice - MSN
Polyrizon faces Nasdaq delisting over shareholder dilution - Investing.com Australia
Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga
Polyrizon faces Nasdaq delisting over shareholder dilution By Investing.com - Investing.com India
Polyrizon Receives Nasdaq Delisting Notice Amid Shareholder Concerns - TipRanks
Polyrizon Receives Nasdaq Delisting Notice - marketscreener.com
Polyrizon receives noncompliance letter from Nasdaq - TipRanks
Polyrizon Announces Receipt of Nasdaq Delisting Notice - The Manila Times
Polyrizon announces preclinical data on nasal protection platform - TipRanks
Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform - Bluefield Daily Telegraph
Revolutionary Nasal Drug Delivery Platform Achieves Perfect Coverage Score in Latest Tests - Stock Titan
Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside - FinancialContent
Polyrizon Ltd. Increases Outstanding Shares Following Warrant Exercises - TipRanks
Polyrizon Ltd. Announces Increase in Outstanding Shares Following Warrant Exercises - TipRanks
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings - Benzinga
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
Polyrizon begins preclinical studies for seizure treatment - Investing.com Australia
Polyrizon announces initiation of preclinical studies for Benzodiazepines - TipRanks
Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment - The Manila Times
Polyrizon begins preclinical studies for seizure treatment By Investing.com - Investing.com Nigeria
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Did Polyrizon Plunge 15.4%? Pipeline Uncertainty, Market Headwinds - AInvest
Polyrizon Ltd Stock (PLRZ) Financials Data
There is no financial data for Polyrizon Ltd (PLRZ). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.40%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):